VZ vs ZBIO · P/E 11, rev $34.25B vs rev $10.0M
Verizon Communications Inc (VZ) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported VZ revenue for 2026-06-30 was $34.25B. Net income was $3.83B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
VZ currently screens at market cap $191.41B and trailing P/E 11.2. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the VZ and ZBIO stock pages for the full models.
Not investment advice.